01 /What it is
Sermorelin is a synthetic 29 amino acid analog of growth hormone releasing hormone (GHRH). It corresponds to the first 29 residues of native GHRH, which researchers consider the bioactive portion of the molecule.
02 /How it works
In growth hormone axis research, Sermorelin is studied as a GHRH receptor agonist that participates in the pulsatile signaling pathway between the hypothalamus and the anterior pituitary. Its mechanism is most often investigated alongside ghrelin receptor agonists.
03 /What researchers explore it for
Researchers have explored Sermorelin in growth hormone pulsatility research, in pairing research with selective ghrelin receptor agonists, and in research on age related changes in the GHRH axis.
04 /Safety and interactions
Research interactions of note include combinations with ghrelin receptor agonists, which are commonly investigated together and can compound observed signaling in research models. Sermorelin is for laboratory research use only and is not for human consumption. Not medical advice. Not intended to diagnose, treat, cure, or prevent any disease.
05 /Research notes
Peptide family: GHRH analogs. Frequently compared with CJC-1295 and Tesamorelin. Commonly researched alongside Ipamorelin, GHRP-2, and GHRP-6. Sermorelin has a substantive regulatory history; the Apothify library lists it for encyclopedia coverage only.
Related peptides
CJC-1295 (no DAC) · Tesamorelin · Modified GRF 1-29